Joana Sales-Dias

Joana Sales-Dias

Auto-generated profile, based on publicly available information

Joana Sales-Dias

BET, Instituto de Biologia Experimental e Tecnológica, (Institute of Experimental and Technological Biology), Oeiras, Portugal; ITQB, Instituto de Tecnologia Química e Biológica António Xavier, (Institute of Chemical and Biological Technology António Xavier), Nova University Lisbon, Oeiras, Portugal

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 July 2017 in Nature
Verified
Journal Article
Open access
PDF file
LMLiliana Mancio-Silva
Liliana Mancio-Silva
KSKsenija Slavic
Ksenija Slavic
MRMargarida T Grilo Ruivo
Margarida T Grilo Ruivo
AGAna Rita Grosso
Ana Rita Grosso
KMKatarzyna K Modrzynska
Katarzyna K Modrzynska
MMMaria M Mota
Maria M Mota
Malaria parasites use a sensing mechanism to moderate their growth in response to the nutrient content of their host. The ability of pathogens to sense and respond to their environment is essential for their virulence and survival. In this study, Maria Mota and colleagues report the discovery that malaria parasites use a sensing mechanism to moderate growth in response to the nutrient content of blood plasma. Malaria parasites actively respond to changes in their host's dietary calorie intake through a rearrangement of their transcriptome, which is accompanied by a change in their replication rate. The authors identify the kinase KIN, which shares homology with the conserved SNF1/AMPKα kinases in mammalian cells and yeast, as a key regulator of the parasite's response to nutrient fluctuations. This work not only reveals a hitherto unknown nutrient-sensing mechanism in Plasmodium parasites, but also identifies KIN as a potential therapeutic target for malaria interventions. The lifestyle of intracellular pathogens, such as malaria parasites, is intimately connected to that of their host, primarily for nutrient supply. Nutrients act not only as primary sources of energy but also as regulators of gene expression, metabolism and growth, through various signalling networks that enable cells to sense and adapt to varying environmental conditions1,2. Canonical nutrient-sensing pathways are presumed to be absent from the causative agent of malaria, Plasmodium3,4,5, thus raising the question of whether these parasites can sense and cope with fluctuations in host nutrient levels. Here we show that Plasmodium blood-stage parasites actively respond to host dietary calorie alterations through rearrangement of their transcriptome accompanied by substantial adjustment of their multiplication rate. A kinome analysis combined with chemical and genetic approaches identified KIN as a critical regulator that mediates sensing of nutrients and controls a transcriptional response to the host nutritional status. KIN shares homology with SNF1/AMPKα, and yeast complementation studies suggest that it is part of a functionally conserved cellular energy-sensing pathway. Overall, these findings reveal a key parasite nutrient-sensing mechanism that is critical for modulating parasite replication and virulence.

2 August 2016 in Cellular Microbiology
Verified
Journal Article
Open access
PDF file
PMPatrícia Meireles
Patrícia Meireles
JSJoana Sales-Dias
Joana Sales-Dias
CACarolina M. Andrade
Carolina M. Andrade
JMJoão Mello-Vieira
João Mello-Vieira
LMLiliana Mancio-Silva
Liliana Mancio-Silva
Miguel PrudêncioMiguel Prudêncio
Miguel Prudêncio
Intracellular pathogens have evolved mechanisms to ensure their survival and development inside their host cells. Here, we show that glucose is a pivotal modulator of hepatic infection by the rodent malaria parasite Plasmodium berghei and that glucose uptake via the GLUT1 transporter is specifically enhanced in P. berghei-infected cells. We further show that ATP levels of cells containing developing parasites are decreased, which is known to enhance membrane GLUT1 activity. In addition, GLUT1 molecules are translocated to the membrane of the hepatic cell, increasing glucose uptake at later stages of infection. Chemical inhibition of GLUT1 activity leads to a decrease in glucose uptake and the consequent impairment of hepatic infection, both in vitro and in vivo. Our results reveal that changes in GLUT1 conformation and cellular localization seem to be part of an adaptive host response to maintain adequate cellular nutrition and energy levels, ensuring host cell survival and supporting P. berghei hepatic development.

1 October 2017 in New Biotechnology
Verified
Journal Article
Closed access
MLMárcia Lamy
Márcia Lamy
AFAndreia Ferreira
Andreia Ferreira
JDJoana Sales Dias
Joana Sales Dias
SBSofia Braga
Sofia Braga
GSGabriela Silva
Gabriela Silva
ABAna Barbas
Ana Barbas

1 September 2016 in Cell Reports
Verified
Journal Article
Open access
MRMargarida T. Grilo Ruivo
Margarida T. Grilo Ruivo
IVIset Medina Vera
Iset Medina Vera
JSJoana Sales-Dias
Joana Sales-Dias
PMPatrícia Meireles
Patrícia Meireles
NGNil Gural
Nil Gural
LMLiliana Mancio-Silva
Liliana Mancio-Silva
Manipulation of the master regulator of energy homeostasis AMP-activated protein kinase (AMPK) activity is a strategy used by many intracellular pathogens for successful replication. Infection by most pathogens leads to an activation of host AMPK activity due to the energetic demands placed on the infected cell. Here, we demonstrate that the opposite is observed in cells infected with rodent malaria parasites. Indeed, AMPK activity upon the infection of hepatic cells is suppressed and dispensable for successful infection. By contrast, an overactive AMPK is deleterious to intracellular growth and replication of different Plasmodium spp., including the human malaria parasite, P. falciparum. The negative impact of host AMPK activity on infection was further confirmed in mice under conditions that activate its function. Overall, this work establishes the role of host AMPK signaling as a suppressive pathway of Plasmodium hepatic infection and as a potential target for host-based antimalarial interventions.

8 January 2014 in Malaria Journal
Verified
Journal Article
Open access
PDF file
VZVanessa Zuzarte-Luis
Vanessa Zuzarte-Luis
JSJoana Sales-Dias
Joana Sales-Dias
MMMaria M Mota
Maria M Mota
The first phase of malaria infection occurs in the liver and is clinically silent. Inside hepatocytes each Plasmodium sporozoite replicate into thousands of erythrocyte-infectious merozoites that when released into the blood stream result in clinical symptoms of the disease. The time between sporozoite inoculation and the appearance of parasites in the blood is defined as the pre-patent period, which is classically analysed by time-consuming and labor-intensive techniques, such as microscopy and PCR.

20 May 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JSJoana Sales-Dias
Joana Sales-Dias
GSGabriela Silva
Gabriela Silva
MLMárcia Lamy
Márcia Lamy
AFAndreia Ferreira
Andreia Ferreira
ABAna Barbas
Ana Barbas
Breast cancer (BC) is the most common type of cancer in women and has a high rate of relapse and death. Notch signaling is crucial for normal breast development and homeostasis. Dysregulation of Notch receptors and ligands has been detected in different BC subtypes and shown to be implicated in tumor development, progression, drug resistance, and recurrence. However, the effects of Notch ligands in various types of BC remain poorly understood. In this study, we investigated the effects of the Notch ligand DLL1 in three different human BC cell lines: MCF-7, BT474, and MDA-MB-231. We showed that DLL1 expression is higher in MCF-7 and BT474 than in MDA-MB-231 cells, and that these cells respond differently to DLL1 downregulation. Functional assays in MCF-7 cells demonstrated that siRNA-mediated DLL1 downregulation reduced colony formation efficiency, migration, proliferation, caused cell cycle arrest at the G1 phase, and induced apoptosis. Gene expression studies revealed that these effects in MCF-7 cells were associated with increased expression of the cell cycle arrest p21 gene and decreased expression of genes that promote cell cycle progression (CDK2, SKP2), and survival (BCL2, BIRC5), unravelling possible mechanisms whereby DLL1 downregulation exerts some of its effects. Moreover, our results demonstrate that treatment with recombinant DLL1 increased MCF-7 cell proliferation and migration, confirming that DLL1 contributes to these processes in this BC cell line. DLL1 downregulation reduced the colony formation efficiency of BT474 cells and decreased the migration and invasion abilities of MDA-MB-231 cells but showed no effects in the proliferation and survival of these cells. These findings provide further evidence that DLL1 exerts carcinogenic effects in BC cells. The dissimilar effects of DLL1 downregulation observed amongst MCF-7, BT474, and MDA-MB-231 cells is likely due to their distinctive genetic and biologic characteristics, suggesting that DLL1 contributes to BC through various mechanisms.